abstract |
Conditionally active receptor agonists that, when activated, bind to IL-2 receptor βṾc heterodimer (IL-2RβṾc), 1L-4 receptor αṾcheterodimer (IL-4RαṾc), or IL-13 receptor a subunit (IL~13 Rα) are disclosed, as are components of the conditionally active receptor agonists and methods for using the conditionally active receptor agonists. |